DOCSLIB.ORG

Icrar2010.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Icrar2010.Pdf ICR ANNUAL REPORT 2010 (Volume 17) - ISSN 1342-0321 - This Annual Report covers from 1 January to 31 December 2010 Editors: Professor: ONO, Teruo Professor: MURATA, Yasujiro Associate Professor: TSUJI, Masaki Assistant Professor: KAWAZOE, Yoshinori Editorial Staff: Public Relations Section: TANIMURA, Michiko TSUGE, Aya KOTANI, Masayo NAKANO, Yukako Published and Distributed by: Institute for Chemical Research (ICR), Kyoto University Copyright 2011 Institute for Chemical Research, Kyoto University Enquiries about copyright and reproduction should be addressed to: ICR Annual Report Committee, Institute for Chemical Research, Kyoto University Note: ICR Annual Report available from the ICR Office, Institute for Chemical Research, Kyoto University, Gokasho, Uji-city, Kyoto 611-0011, Japan Tel: +81-(0)774-38-3344 Fax: +81-(0)774-38-3014 E-mail [email protected] URL http://www.kuicr.kyoto-u.ac.jp/index.html Uji Library, Kyoto University Tel: +81-(0)774-38-3010 Fax: +81-(0)774-38-4370 E-mail [email protected] URL http://lib.kuicr.kyoto-u.ac.jp/homepage/japanese/index.htm Printed by: Nakanishi Printing Co., Ltd. Ogawa Higashi-iru, Shimodachiuri, Kamigyo-ku, Kyoto-city 602-8048, Japan TEL: +81-(0)75-441-3155 FAX: +81-(0)75-417-2050 ICR AN NU AL REPORT 2010 Institute for Chemical Research Kyoto University Volume 17 Pref ace Institute for Chemical Research (ICR) dates back to 1915 with our breadth and depth. In other words, ICR is multidimensional, the founding of the Specialized Center for Chemical Research at and is constantly widening and deepening its research activities. the Faculty of Science, Kyoto Imperial University. The formation We intend to use our strengths to contribute to pioneering research of the Specialized Center was greatly infl uenced by historical as well as to expand the boundaries of chemistry-related fi elds and events. In 1910, Dr. Sahachiro Hata developed salvarsan, a highly further to promote research collaborations, which are not easy in effective drug for syphilis, while conducting research with Dr. conventional graduate schools. Moreover, we aim to utilize our Paul Ehrlich. The effectiveness of this compound eventually strengths as an outstanding center in education in order to produce became widely recognized, and its commercial production began excellent scientists and engineers who can actively contribute to in Germany. Although Japan was importing this drug, the outbreak our global society on the basis of their broad and profound of the World War I ceased the importation, and forced by circum- perspective. ICR is currently executing Global COE Programs in stances the Japanese government requested that the University of collaboration with the Graduate school of Engineering, the Graduate Tokyo and Kyoto University produced salvarsan. The fourth school of Science and Graduate school of Informatics. These Chancellor of Kyoto University, Professor Mitsuru Kuhara, who Programs include “International Center for Integrated Research also happened to be a chemist, received this request. Facilities for and Advanced Education in Material Science (starting from salvarsan production were built with an investment of 20,000 yen, 2007)” encompassing chemistry and materials science fi elds, which is equivalent to about 200 million yen in today’s market. “Center of Excellence for Education and Research on Photonics Production went well, and as income was generated, faculty and Electronics Science and Engineering (from 2007)” involving members, who had a passion for research in chemistry, gathered information science, electrical engineering, and electronics fi elds, from across the University to form the Specialized Center for and “The Next Generation of Physics, Spun from Universality & Chemical Research, which was later expanded and renamed as the Emergence Developing Independent Researchers to Explore New Institute for Chemical Research (ICR) in 1926. The newly estab- Frontiers (from 2008)” covering physics, astronomy, and materials lished ICR soon began to produce outstanding research achieve- chemistry fi elds. ments: research on accelerators by Professor Bunsaku Arakatsu, In addition, ICR is making enthusiastic contribution to the research on synthesized petroleum oil production, and the devel- MEXT Project of Integrated Research on Chemical Synthesis opment of vinylon, which is Japan’s fi rst synthetic fi ber. Almost (2010-2016)”, in collaboration with the Catalysis Research Center all professors at the Institute, including the aforementioned, were at Hokkaido University, the Research Center for Materials also professors at the Faculty of Engineering or Science. However, Science at Nagoya University and the Institute for Materials over time, people began to recognize the importance of having Chemistry and Engineering at Kyushu University. This is the professors dedicated solely to ICR in order to operate ICR with a second stage of the project supported by MEXT through the clear responsibility, as well as the importance of the Institute’s Research and Education Funding for Inter-University Research contribution in training researchers by providing guidance to Project. Furthermore, ICR is currently collaborating with domes- graduate students. Thus, ICR began accepting graduate students tic/oversea universities and research organizations (with 49 offi cial in 1962, and reorganization in 1964 saw the installation of the international collaboration agreements) and has been functioning research division system where each division was led by one of as a Joint Usage/Research Center supported by MEXT, “Frontier/ our dedicated professors. Since the founding of ICR in 1926, our Interdisciplinary Research Core in ICR for Deepening Investiga- basic principle has been to excel in the investigation of basic tion and Promoting Cooperation in Chemistry-Oriented Fields” principles of chemistry and their applications. Through several (since 2010). reorganizations, ICR currently consists of the following fi ve The strong collaboration basis so far constructed in-house research divisions: Division of Synthetic Chemistry, Division of and also with outside ensures our institute to serve as the core of Materials Chemistry, Division of Biochemistry, Division of Environ- global research propellers in chemistry-oriented fi elds. Fortu- mental Chemistry, and Division of Multidisciplinary Chemistry as nately, the four-year quakeproof renovation of the main buildings well as the following three research centers: Advanced Research in Uji campus has just been completed at the end of 2010 together Center for Beam Science, International Research Center for with the establishment of a new lecture hall “Uji Obaku Plaza” in Elements Science (IRCELS), and Bioinformatics Center. Today, 2009. With these highly improved research/education facilities, ICR spans 32 research fi elds (laboratories) with 99 faculty we are further activating ourselves to attain our founding philoso- members and about 240 graduate students. Each laboratory phy. Thus, we respectfully request your continued support and belongs to one of the seven graduate schools which encompass encouragement. science, engineering, pharmaceutical science, a griculture, medi- cine, informatics, human and environmental studies. Our labora- January 2011 tories and the graduate schools work together to provide excellent graduate education. ICR strives to be the “central research center in chemistry” by achieving outstanding results in chemistry and related fi elds, and attracting motivated researchers in these fi elds. Chemistry is a fundamental science, which deals with materials, and its importance, including its contribution to physics and TOKITOH, Norihiro biology, cannot be overemphasiz ed. One of our major strengths is Director iii ICR News 2010 Joint Usage/Research Center: Frontier/Interdisciplinary Research Core in ICR for Deepening Investigation and Promoting Cooperation in Chemistry-Oriented Fields Prof WATANABE, Hiroshi (Vice-Director of ICR) Institute for Chemical Research (ICR) has been functioning, since April 2010, as the Joint Usage/Research Center (JURC) to deepen the investigation and promote the cooperation in chemistry-oriented fi elds. 68 joint research subjects have been adopted this year; please see p.67 for details. Several frontier instruments, including 800MHz Multi-purpose Nuclear Magnetic Resonance Spectrometer and Fourier Transform Ion Cyclotron Resonance Mass Spectrometer, have been newly equipped and utilized in the cooperative researches, and a man- agement offi ce for those common-use instruments has been also organized. The activity of JURC/ ICR will bring a breakthrough into the global researches in the chemistry-oriented fi elds. The management offi ce for the common-use instruments Versatile Super-High Field Fourier Transform Ion Cyclotron Resonance Nuclear Magnetic Resonance (NMR) Mass Spectrometer with 7.05 T Super This 800 MHz NMR can be Conducting Magnet (FT-ICR-Mass) used both for solution- and solid- A Bruker Daltonics SolariX Qq-FT-ICR Mass Spec- state measurements. 5 mmφ mul- trometer, equipped with ESI, APCI, and MALDI ion sources tinuclear double-resonance probe, with CID, ECD, and 5 mmφ inverse detection triple- ETD fragmentation, resonance probe, 10 mmφ multi- enables ultra-high res- nuclear double-resonance probe, olution (FWHM max triple-resonance CP/MAS probe, >1,000,000) and ultra- and high spinning speed CP/MAS high sensitivity (100 probe are available. atmol) mass spectro- metry measurements. iv Division of Multidisciplinary Chemistry, Interdisciplinary
Load more

Recommended publications
  • REVIEW Modern Japanese Medical History and the European In¯Uence
    REVIEW Modern Japanese medical history and the European in¯uence Yoshio Izumi and Kazuo Isozumi1 Department of Neurology, Tokai University School of Medicine, Kanagawa 1 Department of Neurology, Ashikaga Red Cross Hospital, Tochigi, Japan (Received for publication on January 19, 2001) Abstract. Before the ®rst European visited Japan in 1549, traditional Chinese medicine was mainly employed in Japan. Francisco de Xavier, a missionary of the Society of Jesus, tried to promote the introduction of Christianity by providing a medical service for Japanese citizens. However, Japan implemented a national isolation policy in 1639 and cut off diplomatic relations with the rest of the world, except Holland and China. For over 200 years, until the American admiral Matthew Perry forced Japan to open its doors in 1853, Japan learned about western medicine only from doctors of the Dutch merchants' of®ce or from Dutch medical books. After 1853, Western medicine was rapidly introduced into Japan, and great achievements by Japanese medical doctors soon followed, such as the serum therapy for tetanus, the discovery of the plague and dysentery bacilli, the invention of Salvarsan for the treatment of syphilis, and the demonstration of the neurosyphilis spirochete. (KeioJMed50(2): 91±99, June 2001) Key words: Kaitai-Shinsho, Seishu Hanaoka, Siebold, Pompe, Shibasaburo Kitasato Xavier's Visit to Japan and Obtaining the permission of the feudal lord of Satsuma, ``Southern Barbarian Style Surgery'' Shimazu, he engaged in missionary work in the western parts of Japan. According to the record of Nippon- The God of medicine in Europe is Asclepius, but the Seikyo-Shi (History of Western Religion in Japan), person honored as the founder of medicine is Hippo- Xavier nursed sick persons during his missionary work.
    [Show full text]
  • Of Rabbits and Men: the Tale of Paul Ehrlich in Our Modern World Of
    Of Rabbits and Men: The Tale of Paul Ehrlich In our modern world of chemotherapy, antibiotics and antivirals, it might come as a surprise to find that the origin of all these treatments can be traced back to rabbits; the cute and fluffy kind. To understand why, we need to go all the way back to 1882 Berlin. A talented, if aimless, young German doctor, Paul Ehrlich, had just met the great microbiologist Robert Koch. Koch was giving a lecture in which he identified the pathogen responsible for tuberculosis. Ehrlich was instantly fascinated by Koch and microbiology. Unknown to himself, he had just taken the first step on a path that would help change the way disease is tackled forever1. The late 1800’s were a time of dynamic change in the sciences. Charles Darwin had proposed his Theory of Natural Selection and Thomas Edison had given us the light bulb. Amongst the many fashionable topics of the time, some biologists were fascinated by dyes; specifically the staining of living tissue. Spending all day bent over a microscope looking at the pretty colours might not seem like worthwhile science by modern standards, but these dyes had interesting properties. Dyes displayed a high level of specificity; they would only stain certain structures and pass through others. Ehrlich noticed this and soon started to think of applications for these properties. These were times when catching a chill could kill. Many well-known individuals of the time were killed in their prime due to infectious disease. Emily Brontë died from tuberculosis2, René Descartes from pneumonia3 and Pyotr Tchaikovsky died from cholera4.
    [Show full text]
  • Syphilis - Its Early History and Treatment Until Penicillin, and the Debate on Its Origins
    History Syphilis - Its Early History and Treatment Until Penicillin, and the Debate on its Origins John Frith, RFD Introduction well as other factors such as education, prophylaxis, training of health personnel and adequate and rapid “If I were asked which is the most access to treatment. destructive of all diseases I should unhesitatingly reply, it is that which Up until the early 20th century it was believed that for some years has been raging with syphilis had been brought from America and the New impunity ... What contagion does World to the Old World by Christopher Columbus in thus invade the whole body, so much 1493. In 1934 a new hypothesis was put forward, resist medical art, becomes inoculated that syphilis had previously existed in the Old World so readily, and so cruelly tortures the before Columbus. I In the 1980’s palaeopathological patient ?” Desiderius Erasmus, 1520.1 studies found possible evidence that supported this hypothesis and that syphilis was an old treponeal In 1495 an epidemic of a new and terrible disease broke disease which in the late 15th century had suddenly out among the soldiers of Charles VIII of France when evolved to become different and more virulent. Some he invaded Naples in the first of the Italian Wars, and recent studies however have indicated that this is not its subsequent impact on the peoples of Europe was the case and it still may be a new epidemic venereal devastating – this was syphilis, or grande verole, the disease introduced by Columbus from America. “great pox”. Although it didn’t have the horrendous mortality of the bubonic plague, its symptoms were The first epidemic of the ‘Disease of Naples’ or the painful and repulsive – the appearance of genital ‘French disease’ in Naples 1495 sores, followed by foul abscesses and ulcers over the rest of the body and severe pains.
    [Show full text]
  • Curriculum Vitae Paul Ehrlich (*1854 - †1915) German Medical Doctor – Serology and Immunology
    Curriculum Vitae Paul Ehrlich (*1854 - †1915) German medical doctor – serology and immunology 1915 Paul Ehrlich died after a serious illness on 20 August 1915 at Bad Homburg vor der Höhe, Germany- 1912 Honorary citizen of Frankfurt a.M. and his birthplace, Strehlen, Germany 1911 Appointed as “Real Privy Councillor” with the additional title of “Excellency” (the highest civilian honour of the Prussian state) 1909 Discovery of Salvarsan (also called: Dioxy-diamino-arsenobenzol-dihydrochloride or preparation "606“), the first preparation for the treatment of syphilis, in co-operation with his most important co-worker, Sahachiro Hata 1908 Received the Nobel Prize for “Immortal contribution to medical and biological research, particularly to the valency determination of sera preparations”, together with Elia Metschnikow, who discovered phagocytosis 1907 Appointed as privy senior officer of health, honorary doctorate at Oxford 1906 Head of the Georg-Speyer-House for Chemotherapy 1904 Full Honorary Professor of the University of Göttingen and honorary doctorate of the University of Chicago 1903 Award winner of the Great Golden Medal of Science 1899 Head of the “Royal Institute of Experimental Therapy” at Frankfurt am Main 1897 Appointed as Privy Medical Officer of Health Publication of his side-chain theory in an essay “On the determination of the valency of the diphtheria serum” 1896 Appointed as Head of the “Institute for Sera Research and Serum Testing” that had been newly established in Steglitz, near Berlin 1891 Appointed by Robert Koch to the newly established Institute of Infectious Diseases in Berlin (today: Robert Koch Institute). There, he worked on the extraction of diphtheria serum and the determination of its concentration and valency and developed an internationally acknowledged unit of measurement.
    [Show full text]
  • Практикум По Истории Медицины Workbook in History of Medicine
    МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ РЕСПУБЛИКИ БЕЛАРУСЬ БЕЛОРУССКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ КАФЕДРА ОБЩЕСТВЕННОГО ЗДОРОВЬЯ И ЗДРАВООХРАНЕНИЯ ПРАКТИКУМ ПО ИСТОРИИ МЕДИЦИНЫ WORKBOOK IN HISTORY OF MEDICINE Рекомендовано Учебно-методическим объединением по высшему медицинскому, фармацевтическому образованию в качестве учебно-методического пособия для студентов учреждений высшего образования, обучающихся на английском языке по специальности 1-79 01 01 «Лечебное дело» Минск БГМУ 2017 1 УДК 61(076.5)(075.8)–054.6 ББК 5я73 П69 А в т о р ы: Т. П. Павлович, М. Н. Петрова, С. В. Куницкая, Д. С. Ясинская, Ю. И. Ровкач, И. И. Халямина, А. О. Карпечина, Е. К. Анищенко Р е ц е н з е н т ы: канд. экон. наук, доц., зав. каф. менеджмента и экономики соци- альной сферы Белорусского государственного университета И. С. Полоник; каф. обще- ственного здоровья и здравоохранения Витебского государственного ордена Дружбы народов медицинского университета Практикум по истории медицины = Workbook in history of medicine : учебно- П69 методическое пособие / Т. П. Павлович [и др.]. – Минск: БГМУ, 2017. – 34 с. ISBN 978-985-567-838-1. Рассматривается история медицины от первобытного общества до наших дней. Содержит за- дания разного уровня сложности, представленные в виде таблиц, тестов и схем, что позволяет освоить учебный материал в полном объеме. Задания предназначены как для индивидуальной работы, так и для работы на семинарских занятиях по истории медицины. Предназначается для студентов медицинского факультета иностранных учащихся, обучаю- щихся на английском языке по специальности 1-79 01 01 «Лечебное дело». УДК 61(076.5)(075.8)–054.6 ББК 5я73 ISBN 978-985-567-838-1 © УО «Белорусский государственный медицинский университет», 2017 2 Thematic plan of lectures IN THE HISTORY OF MEDICINE FOR THE 1ST YEAR STUDENTS OF THE MEDICAL FACULTY FOR INTERNATIONALE STUDENTS № Lecture Topic Hours 1.
    [Show full text]
  • The Paul Ehrlich Foundation
    The Paul Ehrlich Foundation Office of the Paul Ehrlich Foundation Contents Paul Ehrlich-Stiftung c/o Vereinigung von Freunden und Förderern der Goethe-Universität Theodor-W.-Adorno-Platz 1 Preface 5 60629 Frankfurt am Main E-Mail: [email protected] www.paul-ehrlich-stiftung.de Paul Ehrlich: His Life March 2021 and Achievements 6 Ludwig Darmstaedter: Donation account: Scientist and Friend 12 Deutsche Bank AG IBAN: DE38 5007 0010 0700 0839 00 BIC: DEUTDEFFXXX The Foundation, the Prize and the Role of Hedwig Ehrlich 14 The Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers 17 Preface In honor of the great German doctor and Paul Ehrlich, like all great researchers, was serologist who turned Frankfurt into a way ahead of his time. His research work medical eldorado at the beginning of the laid the cornerstone for the medical stand- 20th century, the Paul Ehrlich and Ludwig ards still valid today. In awarding the Paul Darmstaedter Prize is awarded to scientists Ehrlich and Ludwig Darmstaedter Prize, the from all over the world who have achieved Foundation wishes to encourage scientists all outstanding results in Paul Ehrlich’s field over the world to do what Paul Ehrlich did of work. throughout his entire life: extend medical know-how and make a contribution to the The prize given by the Paul Ehrlich constant struggle against illness and disease- Foundation is one of Germany’s most emi- induced mortality. nent accolades in recognition of outstand- ing achievements in biomedical research. The President of the German Research Foundation (DFG) is Honorary President of the Paul Ehrlich Foundation.
    [Show full text]
  • The Birth of Antibiotics: Cutting a Long Story Short. Part 1
    Article ID: WMC005591 ISSN 2046-1690 The birth of antibiotics: cutting a long story short. Part 1 Peer review status: No Corresponding Author: Dr. Esther Una Cidon, Specialist in Medical Oncology, Member of the British Society for the History of Medicine , Oncology Department, Royal Bournemouth Hospital, Castle Lane East, BH7 7DW - United Kingdom Submitting Author: Dr. Esther Una Cidon, Doctor Specialist in Medical Oncology, Oncology Department, Royal Bournemouth Hospital, Castle Lane East, BH7 7DW - United Kingdom Article ID: WMC005591 Article Type: Original Articles Submitted on:31-Aug-2019, 07:23:13 PM GMT Published on: 04-Sep-2019, 07:42:14 AM GMT Article URL: http://www.webmedcentral.com/article_view/5591 Subject Categories:INFECTIOUS DISEASES Keywords:Penicillin, bacteria, arsenic, mercury, Salvarsan, magic bullets How to cite the article:Una Cidon E. The birth of antibiotics: cutting a long story short. Part 1. WebmedCentral INFECTIOUS DISEASES 2019;10(9):WMC005591 Copyright: This is an open-access article distributed under the terms of the Creative Commons Attribution License(CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Source(s) of Funding: N/A Competing Interests: N/A WebmedCentral > Original Articles Page 1 of 3 WMC005591 Downloaded from http://www.webmedcentral.com on 04-Sep-2019, 07:42:15 AM The birth of antibiotics: cutting a long story short. Part 1 Author(s): Una Cidon E A difficult beginning Prontosil which killed bacteria causing “blood poisoning―. Gerhard Domagk in 1932 injected mice with a lethal dose of a streptococcal infection and then with Prontosil, which cured them.
    [Show full text]
  • Sex, Disease, and Medicine
    . INTRODUCTION Sex, Disease, and Medicine The most remarkable change in patterns of health during the last century has been the largely successful conquest of infectious disease. Less than one hundred years ago diphtheria, tuberculosis, pneumonia, typhoid, and dysentery consti- tuted this nation’s greatest health threats; epidemics could devastate a city or town with tragic speed. In 1918 an outbreak of Spanish influenza claimed more victims than did combat in World War 1.’ Today these diseases are largely un- der control if not virtually unknown. Although there is considerable debate about the reasons for the decline of these infections-some credit medical advances while others have stressed a rising standard of living, better nutrition, and nat- ural changes in the host-parasite relationshipthere is no doubt that we have much less to fear from infectious disease than we did even a generation ago.* Yet, strikingly, venereal diseases are inadequately controlled, if controlled at all. Given the power of the contemporary media, it seems impossible to be un- aware of the current problem. Herpes, a viral infection that is often transmitted sexually, is according to most reports epidemic, affecting perhaps as many as 20 million Americans. With no effective treatments available, it threatens to become endemic. Even more ominous is the new disease known as Acquired Immune Deficiency Syndrome (AIDS). Found primarily among homosexual males, in most cases this disease poses a lethal threat. Again, there is no known effective treatment. Yet even
    [Show full text]
  • Review Antibiotic Discovery: Where Have We Come From, Where Do We Go?
    Review Antibiotic Discovery: Where Have We Come from, Where Do We Go? Bernardo Ribeiro da Cunha 1,*, Luís P. Fonseca 1 and Cecília R. C. Calado 2 1 Institute for Bioengineering and Biosciences (IBB), Instituto Superior Técnico (IST), Universidade de Lisboa (UL); Av. Rovisco Pais, 1049-001 Lisboa, Portugal; [email protected] 2 Departamento de Engenharia Química, Instituto Superior de Engenharia de Lisboa (ISEL), Instituto Politécnico de Lisboa (IPL); R. Conselheiro Emídio Navarro 1, 1959-007 Lisboa, Portugal; [email protected] * Correspondence: [email protected] Received: 5 April 2019; Accepted: 22 April 2019; Published: 24 April 2019 Abstract: Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly approved antibiotics for clinical usage, we are on the verge of not having effective treatments for many common infectious diseases. Historically, antibiotic discovery has been crucial in outpacing resistance and success is closely related to systematic procedures—platforms—that have catalyzed the antibiotic golden age, namely the Waksman platform, followed by the platforms of semi-synthesis and fully synthetic antibiotics. Said platforms resulted in the major antibiotic classes: aminoglycosides, amphenicols, ansamycins, beta-lactams, lipopeptides, diaminopyrimidines, fosfomycins, imidazoles, macrolides, oxazolidinones, streptogramins, polymyxins, sulphonamides, glycopeptides, quinolones and tetracyclines. During the genomics era came the target-based platform, mostly considered a failure due to limitations in translating drugs to the clinic. Therefore, cell-based platforms were re-instituted, and are still of the utmost importance in the fight against infectious diseases. Although the antibiotic pipeline is still lackluster, especially of new classes and novel mechanisms of action, in the post-genomic era, there is an increasingly large set of information available on microbial metabolism.
    [Show full text]
  • From Mercury to Miracle Drugs: Syphilis Therapy Over the Centuries
    From Mercury to Miracle Drugs: Syphilis Therapy Over the Centuries John Parascandola Shortly after Columbus had arrived in the New World, as the fifteenth century drew to a close, a terrible new disease which we now call syphilis appeared in Europe. A controversy developed over whether or not the disease had been imported to Europe from the Americas, beginning with Columbus and his crew, or had existed in Europe earlier, perhaps in a different form. The question of the origin of syphilis is still not firmly resolved today, but at present the evidence seems to be pointing against the American origin theory. The venereal nature of syphilis was recognized relatively early. Once the venereal nature of syphilis was understood, people could be (and were) warned against having intimate relations with individuals who were infected, assuming they could identify the infected. But once one had contracted the disease, what remedies were available to alleviate, if not cure, the malady? Some of those who believed that the pox was the just rewards of immoral behavior questioned whether or not those afflicted with the disease even deserved to be treated. 1 Not surprisingly, when this terrible new disease first appeared, all sorts of remedies were recommended for dealing with it. For example, Torella advised such strange treatments as applying a cock or pigeon flayed alive, or a live frog cut in two, to an infected penis. 2 A major aim of most treatment was to remove the morbid matter causing the disease from the patient. This could be done in various ways, for example, by blood-letting or the use of laxatives.
    [Show full text]
  • Full Text (PDF)
    Drug Discov Ther. 2009; 3(2):37-40. 37 Review From chemotherapy to signal therapy (1909-2009): A century pioneered by Paul Ehrlich Hiroshi Maruta* NPO "NF CURE Japan", Melbourne, Australia. ABSTRACT: Paul Ehrlich (1854-1915), a German Koch (1843-1910) and Paul Ehrlich in Germany. microbiologist who was awarded a 1908 Nobel Pasteur developed a vaccine against rabies, and Koch Prize in Physiology/Medicine for his pioneer work discovered a bacteria which causes TB (tuberculosis), on the antibody production, pioneered the modern and Ehrlich developed the first therapeutic for syphilis. chemotherapy by discovering his magic bullet These three giants are the major figures in the best- for syphilis, called "606" or "Salvarsan" in 1909 selling book "Microbe Hunters" published by Paul de with a Japanese young scientist, Sahachiro Hata Kruif in 1926 (1). Ehrlich was the anchor of 14 microbe (1873-1938) from "Denken" (Institute for Infectious hunters in this book. He developed not only an effective Diseases, now called IMS for Institute for Medical antiserum against diphtheria with Emil von Behring Sciences) in Tokyo. His magic bullet was used to (1854-1917), but also pioneered the chemotherapy eradicate syphilis for more than a half century by developing the first modern chemical medicine, until a more safe and effective antibiotic called "Salvarsan" for syphilis (2). His scientific life was "Penicillin" was introduced to this world towards featured in 1940 MGM film "Dr. Ehrlich's Magic Bullet" the end of WWII by Howard Florey (1898-1968). which I have treasured since my youth (Figure 1). Celebrating this year the 100th anniversary of He was born on March 14, 1854, between Jewish his discovery, this brief review will discuss how parents in Silesia then a part of Germany, but now in Ehrlich, now known as the Father of Chemotherapy, the territory of Poland.
    [Show full text]
  • A History of Syphilis and Its Laboratory Diagnosis
    The Great Pox A History of Syphilis and its Laboratory Diagnosis New World – New disease In 1492 Christopher Columbus sailed west The Fleet of Columbus and found an undiscovered New-World. On his return he and his companions Not all Historians agree that syphilis was a new moved around. There were large armies amassing in disease many believe that it was already present in several areas and large-scale troop movements. brought back many strange tales and Old World. The arguments are complex and only Wherever there are armies there are likely to be illicit treasures and, it is widely believed, syphilis summarised below sexual activities that spread sexually transmitted diseases; these, coupled with troop movements, • The first documented outbreak of syphilis, or "the great – the GREAT POX. hastened the spread of syphilis. Descriptions recorded pox," followed the siege of Naples by the French in by first-hand observers at the time tell of patients with 1494, giving rise to the legend that Columbus’ men had Over the next few decades this infection many pustules, rather than the single pustule usually brought the disease back from the New World. spread like wildfire throughout the known seen today, and with the symptoms of rash and painful • It is said that there is no evidence of treponematoses on swellings that are now associated with secondary world and was, for four and a half mainland Europe prior to 1492. syphilis occurring much more rapidly than they do centuries, the HIV/AIDS of its day. It was • However the bones of a medieval woman found in a today.
    [Show full text]